|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
|TSHA||Taysha Gene Therapies||25.00||4.00||19.05%||794.2M|
You can purchase shares of Taysha Gene Therapies (NASDAQ: TSHA) through any online brokerage.
The latest price target for Taysha Gene Therapies (NASDAQ: TSHA) was reported by Chardan Capital on 2021-04-13. The analyst firm set a price target for 67.50 expecting TSHA to rise to within 12 months (a possible 221.43% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Taysha Gene Therapies (NASDAQ: TSHA) is $21 last updated Tue May 11 2021 20:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Taysha Gene Therapies.
There is no upcoming split for Taysha Gene Therapies.